LifeBridge Health

New Data-Driven Approach for Communities At Risk for Severe COVID-19 Outcomes

Newswise — Beginning this week, a statewide Taskforce on Vulnerable Populations for COVID-19 in Maryland began implementing a data-driven approach to identifying communities and individuals at highest risk for severe outcomes from COVID-19. They are using this data and mapping to guide the deployment of outreach and resources to vulnerable populations including homeless, elderly living in congregate dwellings and those with limited healthcare access.

The taskforce, led by Susan Mani, MD, LifeBridge Health’s Chief Population Health Officer, engaged a company called Socially Determined to leverage information from multiple data sources to generate a COVID-19 risk index for severe outcomes that was mapped on a county, city and neighborhood level throughout Maryland. (see attached examples of data and mapping – darker red areas had highest risk index).

 The risk score for communities and individuals and corresponding maps were shared with municipal health officials.  Those local health officials can take the data and mapping into account along with their local expertise to deploy their outreach, moving high risk groups into hotels for social distancing, testing, etc. 

Additionally, the Taskforce on Vulnerable Populations secured approval from Secretary of Health Robert R. Neall to create and deploy Testing and Manage in Place Teams comprised of EMS personnel and social workers/community health workers to institute measures designed to prevent negative COVID-19 outcomes to the most vulnerable communities. 

 As Testing and Manage in Place Teams are deployed, they are able to provide testing on site and also conduct brief clinical assessments to see if emergency telemedicine visits are needed since there are concerns that people may not be going to the hospital or their doctor’s offices even when they are sick out of fear of COVID. 

Teams are also assessing for social needs such as food availability, financial assistance, temporary housing needs and are connecting vulnerable populations with resources they need, including education about the disease to help them stay safe. 

By using this proactive approach, health officials can identify those at greatest risk of ending up in the hospital or ICU and try to prevent that from happening through early outreach testing and management. We know our vulnerable populations at greatest risk from COVID-19 and this kind of approach is being put in place to prevent negative outcomes as well as prevent the overwhelming EDs and hospitals.  

On a community level, Socially Determined took the following key factors into account when determining COVID-19 susceptibility on a community level:

- Age Distribution

- Community Disease Burden

- Population Density

- Economic Stress

- Exposure Potential

- Infrastructure

 On the individual level, Socially Determined took the following key factors into account:

- Age

- Chronic Disease History

- Social Determinants of Health Risk Data

Testing and Manage in Place Teams are working in communities right now and we can provide you with visuals or access to team members in action in vulnerable areas. We can also connect you with Dr. Mani, experts from Socially Determined as well as public health officials who are using the information to guide their efforts. We can show you what is being done and the impact it is having to reduce the spread of COVID-19 and reducing the burden on healthcare systems throughout the state.

 This is a unique approach to battling COVID-19 that could be adopted nationally. 

 




Filters close

Showing results

110 of 4570
Released: 15-Jan-2021 2:55 PM EST
COVID-19 deaths really are different. But best practices for ICU care should still apply, studies suggest.
Michigan Medicine - University of Michigan

COVID-19 deaths are indeed different from other lung failure deaths, according to two recent studies, with 56% of COVID-19 patients dying primarily from the lung damage caused by the virus, compared with 22% of those whose lungs fail due to other causes. But, the researchers conclude, the kind of care needed to help sustain people through the worst cases of all forms of lung failure is highly similar, and just needs to be fine-tuned.

Released: 15-Jan-2021 2:50 PM EST
45% of adults over 65 lack online medical accounts that could help them sign up for COVID-19 vaccinations
Michigan Medicine - University of Michigan

As the vaccination of older adults against COVID-19 begins across the country, new poll data suggests that many of them don’t yet have access to the “patient portal” online systems that could make it much easier for them to schedule a vaccination appointment. In all, 45% of adults aged 65 to 80 had not set up an account with their health provider’s portal system.

Released: 15-Jan-2021 1:30 PM EST
New England Journal of Medicine publishes COVID-19 treatment trial results
University of Texas at San Antonio

A clinical trial involving COVID-19 patients hospitalized at UT Health San Antonio and University Health, among roughly 100 sites globally, found that a combination of the drugs baricitinib and remdesivir reduced time to recovery, according to results published Dec. 11 in the New England Journal of Medicine.

Released: 15-Jan-2021 12:40 PM EST
DNA test can quickly identify pneumonia in patients with severe COVID-19, aiding faster treatment
University of Cambridge

Researchers have developed a DNA test to quickly identify secondary infections in COVID-19 patients, who have double the risk of developing pneumonia while on ventilation than non-COVID-19 patients.

Released: 15-Jan-2021 12:30 PM EST
Fight CRC To Present Research Findings on The Impact of COVID-19 on the Colorectal Cancer Community at 2021 GI ASCO
Fight Colorectal Cancer

Fight Colorectal Cancer presents abstract at Gastrointestinal Cancer Symposium highlighting the need to address the barriers and opportunities for care within the colorectal cancer community during the COVID-19 pandemic

Released: 15-Jan-2021 12:25 PM EST
Technion to Award Honorary Doctorate to Pfizer CEO Dr. Albert Bourla
American Technion Society

Israel's Technion will award an honorary doctorate to Pfizer CEO and Chairman Dr. Albert Bourla, for leading the development of the novel vaccine against SARS-CoV-2, the virus that causes COVID-19. The honorary doctorate will be conferred at the Technion Board of Governors meeting in November 2021.

Released: 15-Jan-2021 11:30 AM EST
UW researchers develop tool to equitably distribute limited vaccines
University of Wisconsin-Madison

Researchers at the University of Wisconsin School of Medicine and Public Health and UW Health have developed a tool that incorporates a person’s age and socioeconomic status to prioritize vaccine distribution among people who otherwise share similar risks due to their jobs.

Released: 15-Jan-2021 11:20 AM EST
Will Covid-19 kill the high street once and for all?
University of Sheffield

The shift to home working during Covid-19, or ‘Zoomshock’, threatens the survival of local goods and services provided in city centres and business parks

14-Jan-2021 5:00 PM EST
AACI Partners With Federal Vaccine Panel to Promote Cancer Patient Health
Association of American Cancer Institutes (AACI)

AACI was invited last summer to join the Vaccine Consultation Panel (VCP) alongside other leading health and science organizations in the U.S. Through the VCP, AACI has received periodic updates on the development and distribution of COVID-19 vaccines and participated in efforts to educate the cancer center community and the general public on the importance of widespread vaccine uptake.

Released: 15-Jan-2021 8:55 AM EST
The First Dose of the Pfizer Vaccine Gives About 50% COVID Protection, Not 91% Claimed by Those Who Want to Speed Up Immunization
Newswise

The NEJM paper actually states that the efficacy between the first and second doses was found to be 52 percent when given 21 days apart. After the second dose, the efficacy raises to 95 percent.


Showing results

110 of 4570

close
1.09269